{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:50:09Z","timestamp":1791597009797,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012663","name":"Program for Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","award":["254000510004"],"award-info":[{"award-number":["254000510004"]}],"id":[{"id":"10.13039\/501100012663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570252"],"award-info":[{"award-number":["82570252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004609","name":"Henan Provincial Education Development Foundation","doi-asserted-by":"publisher","award":["24A320060"],"award-info":[{"award-number":["24A320060"]}],"id":[{"id":"10.13039\/501100004609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024R1036"],"award-info":[{"award-number":["2024R1036"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022D015"],"award-info":[{"award-number":["2022D015"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515010076"],"award-info":[{"award-number":["2024A1515010076"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018607","name":"Henan Province Science and Technology Innovation Talent Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.isci.2026.117300","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:56:09Z","timestamp":1787604969000},"page":"117300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SEI1 complex silences p53 to drive myeloma progression"],"prefix":"10.1016","volume":"29","author":[{"given":"Rui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-5136","authenticated-orcid":false,"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117300_bib1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/s41467-025-56506-5","article-title":"EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117300_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2026.117300_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay8203","article-title":"Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells","volume":"13","author":"Liu","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.isci.2026.117300_bib4","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood.2022018007","article-title":"Highs and lows of t(4;14) in multiple myeloma","volume":"141","author":"Paiva","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117300_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100643","article-title":"The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma","volume":"41","author":"Paner","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.isci.2026.117300_bib6","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/ajh.27419","article-title":"Still high risk? A review of translocation t(14;16) in multiple myeloma","volume":"99","author":"Mian","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.isci.2026.117300_bib7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2009.016329","article-title":"The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance","volume":"95","author":"Ross","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2026.117300_bib8","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood-2015-06-650242","article-title":"Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?","volume":"126","author":"Chretien","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117300_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/cells10020336","article-title":"Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications","volume":"10","author":"Cardona-Benavides","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.117300_bib10","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","article-title":"Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups","volume":"32","author":"Bolli","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.117300_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41408-024-01059-x","article-title":"A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping","volume":"14","author":"Zou","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.isci.2026.117300_bib12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.isci.2026.117300_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081905","article-title":"Metabolic Vulnerabilities in Multiple Myeloma","volume":"14","author":"Lim","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.117300_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/cells9020287","article-title":"Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma","volume":"9","author":"Flynt","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.117300_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/biomedicines6020059","article-title":"The NF-kappaB Activating Pathways in Multiple Myeloma","volume":"6","author":"Roy","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.117300_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-018-0615-3","article-title":"Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential","volume":"11","author":"Spaan","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.117300_bib17","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1158\/0008-5472.CAN-05-0351","article-title":"Oncogenic transformation by SEI-1 is associated with chromosomal instability","volume":"65","author":"Tang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117300_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ijo.2014.2403","article-title":"Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2\/neu-positive and -negative cells","volume":"45","author":"Jung","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.isci.2026.117300_bib19","article-title":"Chemotherapy-Mediated Induction of PD-L1 via SEI1 Facilitates Myeloma Immune Evasion","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.117300_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2026.117300_bib21","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/onc.2017.48","article-title":"FOXC1: an emerging marker and therapeutic target for cancer","volume":"36","author":"Han","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.117300_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030337","article-title":"Prognostic and Clinicopathological Significance of SERTAD1 in Various Types of Cancer Risk: A Systematic Review and Retrospective Analysis","volume":"11","author":"Mongre","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.117300_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccell.2019.10.001","article-title":"Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy","volume":"36","author":"Han","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117300_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.117300_bib25","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.21037\/tcr-24-23","article-title":"HDAC1: a promising target for cancer treatment: insights from a thorough analysis of tumor functions","volume":"13","author":"Xie","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.isci.2026.117300_bib26","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1093\/emboj\/cdf616","article-title":"MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation","volume":"21","author":"Ito","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2026.117300_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102415","article-title":"p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death","volume":"20","author":"Mrakovcic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117300_bib28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fonc.2018.00665","article-title":"Deregulation and Targeting of TP53 Pathway in Multiple Myeloma","volume":"8","author":"Jovanovi\u0107","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117300_bib29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117300_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.sbi.2020.11.005","article-title":"An integrated view of p53 dynamics, function, and reactivation","volume":"67","author":"Demir","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.isci.2026.117300_bib31","article-title":"Bisphosphonates for Paget's disease of bone in adults","volume":"12","author":"Corral-Gudino","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.isci.2026.117300_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33665","article-title":"Flow cytometry-based quantitative analysis of cellular protein expression in apoptosis subpopulations: A protocol","volume":"10","author":"Alshehade","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.isci.2026.117300_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau9087","article-title":"Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease","volume":"11","author":"Liu","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.117300_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8949","article-title":"Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma","volume":"8","author":"Liu","year":"2016","journal-title":"Sci. Transl. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226026787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226026787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:07:31Z","timestamp":1791594451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226026787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589004226026787"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117300","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SEI1 complex silences p53 to drive myeloma progression","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117300"}}